CCL2 and cervical cancer: Another study showed that Cx43 may be modified by SUMO-1/2/3 in human cervical cancer cells, HeLa-CCL2 transfected with Cx43 [43], indicating that Cx43 SUMOylation could be cell-type-dependent.